Vitol paid out $5.9 billion to shareholders in 2025, filings show - Reuters
Vitol paid out $5.9 billion to shareholders in 2025, filings show Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPT0JrSllCWmZfWkZ5aF8wcTNBSXBOcllCUVFkVW9CazJVem1KMGhGU2g4c2N5S1RnQzUyRVllWTRIbElDT0F4Z1d6cjdkc2J5V1k0WEpLNHlTbXhLbmhqdEN0NGRZcG1yMXp4N0hEWTRYUXJTd2xDXzRXRENZamphUTlCcGQwc2VaQi1rRUwtUEQzVzYzT1R3QnlFUW4yY2JaOTl2Q2F6dnlqZGdO?oc=5" target="_blank">Vitol paid out $5.9 billion to shareholders in 2025, filings show</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say - Reuters
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say Reuters
October 8, 2026 at 09:37 PMUK's Pennon seeks £550 million fresh capital as new CEO overhauls utility; shares drop - Reuters
UK's Pennon seeks £550 million fresh capital as new CEO overhauls utility; shares drop Reuters
October 7, 2026 at 10:33 AMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMLevi Strauss lifts annual profit outlook on tariff refunds, holiday demand - Reuters
Levi Strauss lifts annual profit outlook on tariff refunds, holiday demand Reuters
October 7, 2026 at 10:10 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMDental firm vVardis reveals revenue surge in US IPO filing - Reuters
Dental firm vVardis reveals revenue surge in US IPO filing Reuters
October 9, 2026 at 07:31 PM